Related by context. All words. (Click for frequent words.) 77 colorectal bladder 77 ovarian breast 73 ovarian pancreatic 73 ovarian colon 72 pancreatic prostate 71 pancreatic lung 71 lung pancreatic 70 prostate ovarian 70 metastatic colorectal 70 breast uterine 70 prostate colon 69 colorectal lung 69 gastric pancreatic 69 kidney urologic 69 candidates Azedra TM 69 uterine ovarian 69 bladder ovarian 69 cervical prostate 68 breast endometrial 68 CYT# potent vascular disrupting 68 pancreatic colon 68 oncolytic virus therapies 68 colorectal prostate 68 endometrial ovarian 68 inflammatory autoimmune diseases 68 pancreatic bladder 68 colorectal ovarian 68 basal cell carcinoma squamous 68 castration resistant hormone refractory 67 prostate pancreatic 67 endometrial breast 67 rheumatoid arthritis thrombocytopenia 67 breast pancreatic 67 acid phosphatase PAP 66 BRAF mutant 66 prostate lung 66 deCODE BreastCancer 66 Epigenomics proprietary 66 uterine cervical 66 accumulate preferentially 66 bladder cancers 66 ovarian lung 66 LungAlert TM 66 gastrointestinal stromal tumors GISTs 66 ovarian prostate 66 Squamous cell 65 epithelial tumors 65 lymphomas leukemias 65 Basal cell 65 lung colorectal 65 penile cancers 65 breast ovary 65 ovary uterus 65 colorectal cancers 65 deCODE ProstateCancer TM 65 precursor lesions 65 adhesion molecule EpCAM expressing 65 colorectal gastric 65 sirtuin inhibitor program 65 pancreas esophagus 65 DNA methyltransferase inhibitors 65 prostate colorectal 65 cervical uterine 65 cause cardiac channelopathies 65 colon pancreas 65 Epstein Barr Virus EBV 65 bladder prostate 65 Immunotherapeutic 65 Evoltra ® 65 endometrial cancers 65 gastro intestinal inflammation 65 LHRH receptor positive 64 ovarian endometrial 64 hormone refractory prostate 64 BRAF mutated 64 IgG1 monoclonal antibody 64 prostate breast 64 targeted radiotherapeutic 64 carcinoma HCC 64 gastrointestinal stromal 64 lung ovary 64 leukemia multiple myeloma 64 Colon polyps 64 myelofibrosis polycythemia vera 64 colorectal pancreatic 64 bladder cervix 64 colon pancreatic 64 BC SeraPro ™ 64 cirrhosis liver failure 64 essential thrombocythemia ET 64 pelvic malignancies 64 GVAX ® 64 MassARRAY ® 64 Zemiva TM 64 HER2 amplified 64 colon ovarian 64 ARRY # 63 RNAi therapeutic targeting 63 romazarit 63 adenocarcinomas 63 dysplastic lesions caused 63 include Altastaph TM 63 chimeric monoclonal antibody 63 leukemias lymphomas 63 orally administered inhibitor 63 cervix colon 63 Onalta TM 63 5 HT2A serotonin 63 therapeutic monoclonal antibody 63 metastatic pancreatic 63 KRAS mutant 63 gastric cancers 63 breast ovarian 63 ovarian uterine 63 PNP inhibitor 63 HuCNS SC ® 63 resistant hormone refractory 63 R sorafenib tablets 63 M2 subunit 63 Uterine cancer 63 unresectable tumors 63 Squamous 63 hormone gastrin 63 bacterial biothreat agents 63 novel VDA molecule 63 include ColorectAlert TM 63 recurrent ovarian 62 vaginal lesions 62 polysaccharide polymer 62 BRCA deficient 62 Septin9 62 cardio metabolic diseases 62 acetonide FA 62 novel therapeutic antibodies 62 ErbB2 positive 62 molecular abnormalities 62 DCVax R 62 pancreatic colorectal 62 ductal carcinomas 62 targets Galectin receptors 62 leukemia lymphomas 62 orally bioavailable mimics 62 T1c 62 lung ovarian 62 skeletal metastases 62 gastric adenocarcinoma 62 hereditary breast 62 hypercholesterolemia liver 62 gastrointestinal malignancies 62 ovarian cervical 62 colon prostate 62 KRAS oncogene 62 oral picoplatin 62 Colorectal cancer CRC 62 metastatic gastric 62 benign neoplasms 62 oesophageal adenocarcinoma 62 invasive lobular 62 Nucleic Acid Detection Immunoassay 62 alpha folate receptor 62 R Saizen R 62 hormonally sensitive 62 Basal Cell 62 papillary renal cell carcinoma 62 Sezary syndrome 62 leukemia myeloma 62 pancreatic ovarian 62 Factor Receptor 62 refractory chronic lymphocytic 62 colorectal breast 62 miRview TM 62 prostate carcinomas 62 Personalized Immunotherapy 62 Inc. AMEX YMI 62 Intravenous Human 62 abnormal p# 62 Cytomegalovirus CMV 62 Endometrial cancer 62 ZFP Therapeutics 62 grade squamous intraepithelial 62 lung esophageal 62 MCSP respectively 62 HER2 ErbB2 62 eIF 4E 62 BCG refractory carcinoma 62 oligodendrogliomas 61 basal cell carcinoma BCC 61 neovasculature 61 renal cell carcinomas 61 Li Fraumeni 61 Provectus Pharmaceuticals specializes 61 Menopausal hormone therapy 61 NPC 1C 61 HTS assay 61 Fludara ® 61 CDK cyclin dependent 61 metastatic neuroendocrine tumors 61 hypereosinophilic syndrome 61 delivers fluocinolone acetonide FA 61 prostate cancer antigen prostatic 61 HuMax 61 cervical ovarian 61 commercialize deforolimus 61 metastatic bladder 61 HER2 overexpression 61 treat musculoskeletal metabolic 61 HPV vaccine protects 61 PGL# 61 solar keratosis 61 hormonally responsive 61 breast colorectal 61 pathophysiological effects 61 vinca alkaloid 61 included exfoliative dermatitis 61 lung prostate 61 endocrine therapies 61 investigational immunotherapy 61 HER2 positive breast 61 dermatological disorders 61 Nonalcoholic fatty liver 61 Upregulation 61 neuroendocrine cancers 61 A3 adenosine receptor 61 recurrent metastatic 61 induced mucositis 61 Vicinium TM 61 cisplatin resistant 61 lung colon 61 incontinence erectile dysfunction 61 microsphere therapy 61 Carcinoid tumors 61 Genotyping Test 61 Human papillomavirus HPV 61 breast carcinomas 61 nonmelanoma 61 uterine cervix 61 Human papillomavirus 61 relapsed leukemia 61 Hepatocellular 61 castrate resistant 61 liver cancers hypercholesterolemia 61 metastatic HER2 positive 61 ADAMTS# 61 ribonucleotide reductase clinically validated 61 Epidermal Growth Factor Receptor 61 Vidaza ® 61 pancreatic gastric 61 endometrial hyperplasia 61 VALSTAR TM 61 melanoma ovarian 61 specific lectin receptors 61 ovarian cancers 61 interstitial cystitis IC 61 deCODE AF TM 61 tongue mouth pharynx 61 esophagus pancreas 61 PARP inhibition 60 thalidomide Thalomid 60 immunologic diseases 60 testicular cancers 60 molecular imaging radiopharmaceutical 60 MYH9 gene 60 anti PlGF 60 selective kinase inhibitor 60 uterine cancers 60 chronic eosinophilic leukemia 60 benign prostatic hyperplasia enlarged 60 mTOR mammalian target 60 BRCA1 BRCA2 60 metastatic androgen independent 60 epithelial cancers 60 whose tumors overexpress 60 hypermethylated 60 tubulin inhibitor 60 cervical vulvar 60 CCR9 antagonist 60 throughput RNAi 60 nonmelanoma skin cancers 60 cryptococcosis 60 anti CD3 60 histone deacetylase HDAC 60 poly ADP ribose polymerase 60 histone deacetylase inhibitor 60 non resectable metastatic 60 LRP5 60 hormone receptor negative 60 peritoneal carcinomatosis 60 antiangiogenesis therapies 60 Monoclonal antibody 60 Sudhir Agrawal D.Phil 60 GSTP1 60 HBeAg negative 60 Alfacell proprietary ribonuclease 60 c MET 60 NS5b 60 Intravenous CP 60 cervical carcinoma 60 Familial Adenomatous Polyposis FAP 60 HER1 60 HepDirect prodrug 60 infectious diseases autoimmune diseases 60 nonmetastatic 60 #T# L1 60 pancreatic endocrine 60 anal penile 60 Papillary 60 abnormal pap tests 60 vaginal candidiasis 60 novel peptides 60 esophageal cancers 60 human papilloma viruses 60 squamous cell lung cancer 60 Endometrial 60 PRESEPT study 60 colorectal adenoma 60 targeted antifolate 60 antisense inhibitors 60 personalized cellular immunotherapy 60 TRIOLEX HE# 60 MOVIPREP R 60 distal colon cancer 60 chronically immunosuppressed solid 60 cisplatin gemcitabine 60 immuno therapeutic 60 tests miRview TM 60 adrenocortical cancer 60 humanized monoclonal antibodies 60 metastatic malignant 60 allogeneic HSCT 60 product platforms AZX# 60 treating sarcoma testicular 60 Unigene nasal calcitonin 60 Peginterferon alfa 2b 60 GRNOPC1 contains 60 including thyroiditis RA 60 antibody MAb 60 commercializes oncology 60 Tay Sachs thalassemia 60 esophagus colon 60 cutaneous T 60 Entamoeba histolytica 60 CYP#A# CYP#D# 60 Human papillomaviruses 60 hematological diseases 60 Leukemias 60 secondary hyperparathyroidism 60 gastric cardia 60 Tr DNA 60 nonproliferative 60 osteosarcomas 60 lobular carcinoma 60 anti gastrin monoclonal 60 molecular diagnostic assays 60 HuMax TAC 60 forodesine 60 Cholangiocarcinoma 60 Alferon LDO 59 products MKC# PP 59 oral ghrelin agonist 59 precancerous cervical 59 penile anal 59 Modrenal R 59 MAGE A3 ASCI 59 ocular disorders 59 K ras mutations 59 Polymorphisms 59 protein tyrosine phosphatase 1B 59 leiomyomas 59 PROGENSA R 59 cholangiocarcinoma 59 PIK3CA 59 dietary supplement formulated 59 myeloproliferative neoplasms 59 Trichomonas vaginalis 59 prostate cancer CaP 59 microtubule inhibitor 59 CTAP# Capsules 59 radionuclide therapy 59 collagen vascular 59 Rosetta Genomics microRNA 59 situ LCIS 59 HER2 positive metastatic 59 lintuzumab SGN 59 lymphoproliferative disease 59 hyaluronidase enzyme 59 prostate bladder 59 vinca alkaloids 59 DNA methylation biomarkers 59 Oncosphere System 59 Factor VIIa 59 cellular immunotherapy 59 infection epistaxis dyspnea exfoliative 59 endoluminal stent graft 59 overactive bladder VANTAS R 59 PCA3 gene 59 rxRNA 59 adenomatous polyps 59 novel immunotherapies 59 chemotherapy cisplatin 59 promoter hypermethylation 59 urinary bladder wall 59 dasatinib Sprycel 59 adipogenic 59 endometrial kidney 59 gene BRCA2 59 myelodysplastic myeloproliferative diseases 59 pancreatic islet cell 59 colorectal carcinoma 59 vaginal cancers 59 receptor tyrosine kinase inhibitor 59 anticoagulant reversing agent 59 gastric carcinoma 59 Receptors GPCRs 59 acne impetigo 59 Helicobacter pylori infection 59 situ CIS 59 stem cells CSCs 59 neoplasias 59 BRAF V#E 59 cytolytic 59 glutamic acid decarboxylase 59 FUSILEV enhances 59 tumor metastases 59 AEG# 59 basal cell skin 59 SuperAntibody 59 HAAH 59 DELATESTRYL R 59 methylation markers 59 NMP# R 59 MKC# MT 59 Systemic lupus erythematosus 59 selectively inhibited 59 invasive ductal 59 Renal Cell Carcinoma RCC 59 LymphoStat B belimumab 59 proprietary biomaterials 59 HER2 receptor 59 hypervascular tumors 59 Prodarsan R 59 TMEM#B 59 thymidylate synthase TS 59 Soft tissue sarcomas 59 pediatric acute lymphoblastic 59 metastatic carcinoma 59 lymphoid tumors 59 using VIAdel TM 59 Darapladib 59 NMP# 59 cervix vagina 59 EGFR HER2 59 vascular disorders 59 Ceragenin ™ 59 cachexia anti infectives 59 colon esophageal 59 metastatic renal 59 Estrogen receptor positive 59 humanised antibody 59 vivo fluorescence imaging 59 receiving chemoradiation therapy 59 prostate carcinoma 59 papillomaviruses 59 Adenomas 59 Chronic myeloid leukemia CML 59 huC# DM4 59 acute myeloid 59 Fibroblast 59 potent antiproliferative 59 TNF blocker therapy 59 selective angiogenic kinase inhibitor 59 myeloproliferative diseases 59 TTR amyloidosis 59 therapeutic peptide 59 ActA 59 bladder colon 59 targets EpCAM expressing 59 Affibody ® molecules 59 adenomatous 59 RECOTHROM ® 59 Ovarian Cancers 59 cervical intraepithelial neoplasia 59 chemosensitizer 59 CDH1 59 GVAX cancer 59 pregnancy bacterial vaginosis 59 Ribavirin causes 59 breast colon 59 coagulation disorders 59 HER2 HER2 59 molecularly targeted therapy 59 immunotherapeutic approaches 59 FGFR 59 pan HDAC inhibitor 59 breast cervical 59 testicular germ cell 59 PDGF receptor 59 successfully commercialize Iluvien 59 metastatic prostate 59 Injectable Suspension 59 Chlamydia trachomatis infection 59 lymphoid malignancies 59 ATRA IV 59 Mammastatin 59 esophageal gastric 59 diffuse gastric 59 radiation chemoradiation 59 AcryMed Incorporated 59 nonsmall cell lung cancer 59 Cobalamin TM mediated 59 Advanced Renal Cell 59 gastrointestinal cancers 59 phosphate S1P 59 metaglidasen 59 hormone refractory metastatic prostate 59 small molecule agonists 59 recurrent NSCLC 59 fusion enhancers 59 VivaGel ™ 59 molecular biomarkers 59 cMET 59 demonstrated antitumor activity 58 progressive metastatic prostate 58 radiotherapeutic 58 aneurysms AAA 58 biologic therapeutics 58 Vitrasert R 58 c Raf kinase 58 biliary cancer 58 agonistic human 58 refractory metastatic 58 serogroup B 58 formerly LymphoStat B 58 Liprotamase 58 XL# inhibits 58 c KIT 58 sodium thiosulfate STS 58 IMA# 58 Hodgkin lymphoma HL 58 diseases bone metastasis 58 immunotherapeutic vaccine 58 metachronous 58 lung cancer NSCLC 58 colon breast 58 serine threonine 58 potently inhibit 58 Thyroid nodules 58 Veronate R 58 CEA CD# Her2 58 depsipeptide 58 transplantation HCT 58 Luveris R Ovidrel R 58 P2V TM 58 antimitotic 58 proliferative disorders 58 AML MDS 58 anticancer therapeutics 58 Surgical resection 58 immuno inflammatory diseases 58 Shark cartilage 58 leukemia lymphoma multiple myeloma 58 hyperplasia BPH 58 colorectum 58 carcinoembryonic antigen 58 Chronic Lymphocytic Leukemia CLL 58 node metastases 58 CRTH2 58 histologic subtype 58 Androgens 58 prostate cancer benign prostatic 58 topical anti infectives 58 immunoassay kits 58 modified glutathione analog 58 eTag assays 58 simplex virus 58 Surface Plasmon Resonance SPR 58 nasopharyngeal cancer 58 nodal metastasis 58 molecular imaging radiopharmaceuticals 58 Adnectin 58 VALSTAR 58 primary hyperparathyroidism 58 alvespimycin 58 immatics 58 inhibit oxidative stress 58 imatinib Gleevec 58 Insegia 58 multifactorial disease 58 tumors GIST 58 syngeneic 58 Janus kinase 58 hip osteonecrosis avascular 58 metastatic liver 58 DNA methyltransferases 58 ELADUR ™ 58 leukaemias 58 RAF kinase VEGFR 58 palonosetron hydrochloride Injection Dacogen 58 tiapamil 58 ErbB1 58 superficial basal cell carcinoma 58 hepatocellular carcinoma liver 58 metastatic HER2 negative 58 HG PIN 58 antisense inhibition 58 investigational monoclonal antibody 58 precancerous tumors 58 autoimmune inflammatory 58 Alessandro Riva 58 Angiotensin converting enzyme 58 S#P# 58 Elotuzumab 58 aplastic anemia AA 58 parathyroid carcinoma 58 Benign breast 58 anaplastic lymphoma kinase ALK 58 BRACAnalysis ® 58 Onalta ™ 58 Ferring Pharmaceuticals specializes 58 sleeping sickness trypanosomiasis 58 invasive carcinoma 58 SERMs 58 gastroesophageal 58 diagnostic assays 58 TTR gene 58 pulmonary metastases 58 pain palliation 58 Thrombin topical Recombinant 58 miRview meso 58 TNFerade ™ 58 grade cervical intraepithelial 58 biliary tract 58 oral prodrug 58 HER2 neu 58 NeutroSpec TM 58 oral squamous cell 58 myoepithelial 58 OvaRex R 58 EGFR TK 58 III EGFRvIII 58 DGAT1 inhibitors 58 androgen independent 58 thrombo embolic 58 ® bortezomib 58 squamous cell carcinoma SCC 58 rotavirus shingles 58 CD# expressing 58 OMP #M# 58 thyroid parathyroid 58 haematopoietic 58 AstraZeneca Arimidex 58 aerodigestive tract 58 TLR9 agonists 58 MEK inhibitors 58 investigational therapies 58 Acute lymphoblastic leukemia 58 Aviptadil 58 prophylactic vaccines 58 Cathepsin B 58 nasopharyngeal carcinoma 58 colon rectum breast 58 recombinant plasma 58 relapsed MM 58 molecular chaperone regulation 58 grade serous ovarian 58 therapeutic anticancer 58 Ph + acute lymphoblastic 58 advanced hepatocellular carcinoma 58 Hepatocellular Carcinoma HCC 58 FISH fluorescence 58 atopic dermatitis neonatal 58 pre cancerous actinic 58 CpG island 58 ductal cancer 58 thalassemia sickle cell 58 HyperAcute 58 cause mesothelioma asbestosis 58 chemokine receptors 58 dermatology therapies 58 mesothelioma asbestosis 58 malignant ovarian 58 cosmetic cosmeceutical products 58 humanized monoclonal 58 Chlamydia pneumoniae 58 RNA antagonist 58 severe hypersensitivity reactions 58 lymphoproliferative disorders 58 Wafer polifeprosan 58 demethylating agents 58 Soft Tissue Sarcoma 58 sapropterin dihydrochloride Tablets 58 Tarceva TM 58 oncologic diseases 58 diagnostic biomarker 58 Peritoneal mesothelioma 58 ionotropic glutamate receptor antagonists 58 OnDose TM 58 malignant fibrous histiocytoma 58 mutated K ras 57 gene rearrangements 57 Peutz Jeghers syndrome 57 esophageal pancreatic 57 therapeutic monoclonal antibodies 57 molecular diagnostic kits 57 RRM1 57 brivanib 57 NADiA 57 POTELLIGENT ® 57 oncogenesis 57 anti CD# antibodies 57 OncoVex 57 Peyronie disease Frozen Shoulder 57 small molecule thrombopoietin 57 metastatic ocular 57 orthotopic model 57 IGF IR 57 HER2 positivity 57 Accelerated Partial Breast Irradiation 57 breast cancer subtypes 57 MediGene focuses 57 molecule epidermal 57 lung carcinomas 57 squamous intraepithelial lesions 57 sPLA2 57 thymidylate synthase 57 Renal cell carcinoma 57 premalignant lesions 57 external genital lesions 57 hematologic disorders 57 treat refractory angina 57 Onalta 57 proprietary radiolabeled monoclonal 57 VANTAS ® 57 esophageal tumors 57 Nasdaq HALO biopharmaceutical 57 subependymal giant cell 57 refractory Hodgkin 57 signal transduction inhibitors 57 VeraTag 57 p# mutations 57 advanced HER2 positive 57 MKC# MKC# PP 57 BCG refractory 57 Metastases 57 cyclin dependent kinase inhibitor 57 myeloproliferative disorders 57 basal epithelial 57 APOL1 57 Malignant Melanoma 57 SETDB1 57 mesenchymal cell 57 metastatic lymph nodes 57 myeloperoxidase 57 adrenergic regulation 57 treating cancerous tumors 57 catheter occlusion 57 advanced adenoma 57 bevacizumab Avastin ® 57 thromboxane A2 57 ovarian colorectal 57 photodisinfection 57 commonly mutated genes 57 grade cervical dysplasia 57 oncogenic transformation 57 Cryptococcus neoformans 57 abnormal pap smears 57 thetreatment 57 hematological disorders 57 hypophosphatasia 57 Initiates Enrollment 57 advanced pancreatic neuroendocrine 57 epithelial tissues 57 vitro diagnostic tests 57 potent inducer 57 Squamous Cell 57 gefitinib Iressa 57 Retisert ® 57 MSH2 57 FGFR2 57 Mucositis 57 Predictive medicine 57 prostate testicular 57 Shows Promise Against 57 Exherin TM 57 peptidic compound 57 Surfactant Replacement Therapies SRT 57 Aurora kinase 57 squamous cell carcinomas 57 antibody MT# 57 neoplastic diseases 57 beta islets 57 BRCA2 mutations 57 equine osteoarthritis 57 antiproliferative effects 57 EGFr expressing metastatic colorectal 57 refractory colorectal cancer 57 gynecologic malignancy 57 pulmonary metastasis 57 Sopherion 57 AttoSense 57 serous ovarian cancer 57 targeted anticancer therapies 57 recombinant fusion 57 thromboembolic disease 57 ductal breast cancer 57 immunological diseases 57 colorectal cancer CRC 57 albumin bound paclitaxel 57 systemic anaplastic large 57 thyroid peroxidase 57 oncogenic HPV 57 untreated metastatic melanoma 57 developing Surfactant Replacement 57 gastric corpus 57 interleukin IL -# 57 including eniluracil ADH 57 coronary stent merged 57 Carcinomas 57 liver metastasis 57 vascular disrupting agents 57 anthracycline taxane 57 Ii protein 57 JAK inhibitors 57 rusalatide acetate 57 Dendreon investigational 57 E7 proteins 57 monoclonal antibody therapeutics 57 BRAF kinase 57 Cotara ® 57 detect precancerous lesions 57 keloid scarring 57 Acute leukemia 57 FGFR3 57 bone marrow lymph nodes 57 thyroid carcinomas 57 Idiopathic pulmonary fibrosis 57 cholesteryl ester transfer 57 Fibroblast Growth Factor Receptor 57 FullTerm 57 Clusterin 57 signal averaging electrocardiography 57 vidofludimus 57 Pruvel TM 57 inherited mutations 57 Myocet 57 Panzem R NCD 57 TransVax ™ 57 monoclonal antibody IgG1 Mab 57 detecting precancerous 57 Epstein Barr virus EBV 57 druggable targets 57 Cyclin E 57 muscarinic receptor agonist 57 RAS RAF MEK 57 EHT AGN 57 finasteride Proscar 57 K RAS 57 P#X# 57 tested eribulin 57 Aplidin R 57 recombinant biopharmaceutical 57 Ibis T# TM 57 cell adhesion molecule 57 Acute myeloid leukemia 57 stem cell pluripotency 57 epithelial ovarian 57 HBV HCV 57 product ColonSentry TM 57 IAP inhibitor 57 Medullary thyroid cancer 57 antiangiogenesis 57 malignant pancreatic 57 gastrointestinal mucositis 57 inflammation autoimmune diseases 57 mesotheliomas 57 NMIBC 57 HH GLI 57 post transplant lymphoproliferative 57 PORxin TM platforms 57 colon rectal 57 radiolabeled TM# 57 using Innocoll proprietary 57 breast cancer genes BRCA1 57 recurrent epithelial ovarian 57 squamous cell cancer 57 androgen receptor AR 57 c MYC 57 ALK inhibitors 57 taxane chemotherapy administered 57 plaque buildup restricts 57 fungal infections malaria tuberculosis 57 mSEPT9 biomarker 57 irreversible inhibitor 57 Delta opioid receptor 57 Combivir Kivexa 57 lymphoma multiple myeloma 57 Aromatase 57 treat dysmenorrhea 57 non nucleoside inhibitor 57 granulosa cell 57 Her2 positive 57 inhibit EGFR 57 BRAF mutations 57 HER2 expression 57 Epithelial ovarian cancer 57 luteinizing hormone releasing 57 Modrenal 57 Autoantibodies 57 histological subtype 57 NSCLC tumors 57 paclitaxel Taxol 57 molecular imaging pharmaceuticals 57 drugable targets 57 colon cancers 57 ZACTIMA TM ZD# 57 nonhereditary 57 anal cancers 57 thromboembolisms 57 adipose derived regenerative 57 cetuximab Erbitux 57 urogenital tract 57 sarcomatoid 57 psoriasis Crohn disease 57 MET amplification 57 TLE3 57 Anticalins R 57 MGd 57 theranostic 57 ErbB3 57 rhabdoid 57 Li Fraumeni Syndrome 57 castrate resistant prostate cancer 57 anal lesions 57 TGF alpha 57 haematological cancers 57 intra arterial chemotherapy 57 autologous cellular therapy 57 dyslipidemia abnormal 57 dyslipidemia hypertension diabetes 57 anthrax botulism typhoid 57 lung adenocarcinomas 57 molecular diagnostic assay 57 mTOR inhibitors 57 OLIGON technology 57 untreated metastatic pancreatic 57 interferon beta 1a infertility 57 ParAllele 57 LymphoStat B TM 57 cervix uteri 57 chlamydia trachomatis 57 Proxinium TM 57 hepatocellular cancer 57 premalignant lesion 57 androgen dependent 57 include ClindaReach TM 57 mda 7 56 nonalcoholic steatohepatitis 56 intestinal polyps 56 Human papilloma virus 56 Achieves Primary Endpoint 56 biologic pathway 56 Irinotecan 56 Crofelemer budesonide foam 56 Apaziquone 56 trans retinoic acid 56 Vandetanib 56 intraepithelial neoplasia 56 Amgen Neulasta R 56 Ischaemic heart 56 arterial calcification 56 breast prostate 56 Myelodysplastic syndromes MDS 56 immunochemical 56 alpha1 antitrypsin AAT deficiency 56 diagnostic molecular imaging 56 Immunohistochemical staining 56 GISTs 56 pulmonary fungal infections 56 Smac mimetic 56 TNF Blockers 56 replacement trauma craniomaxillofacial 56 GVAX R 56 commercializing therapeutic 56 Telatinib 56 TRANSDUR ™ 56 hormone LHRH antagonist 56 #T# tumor 56 atypical hyperplasia 56 metaplasia 56 gynecologic procedures 56 JAK2 kinase 56 activin receptor type 56 lobular cancer 56 splice variants 56 MALT lymphoma 56 cytological 56 Cervista HPV HR 56 selective modulator 56 carbohydrate polymers 56 Cloretazine